ArticleFrontiers in public health2025
Public understanding of medical cannabis in Poland 7 years after legalization: findings from a cross-sectional study.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Readiness to Use Medicinal Marijuana in the Practices of Polish Family Physicians.Journal of clinical medicine · 2026Article
- Mental health consequences of contemporary cannabis use in Europe: potency, patterns of use, and health system context.Frontiers in psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Medical cannabis has been legally available in Poland since 2017, yet its integration into routine clinical practice remains limited. This study investigates public attitudes toward medical cannabis, therapeutic awareness, and the perceived readiness of the healthcare system 7 years after legalization. Methods: A cross-sectional survey was conducted in July 2025 using the computer-assisted web interviewing (CAWI) method on a nationally representative sample of 1,113 adults (aged 18-84). The questionnaire assessed opinions on the legalization of medical cannabis, willingness to undergo cannabinoid-based therapy, perceptions of physician and patient knowledge, and support for home cultivation under medical supervision. Multivariable logistic regression was used to identify sociodemographic predictors of key attitudes. Results: A substantial majority of respondents supported the legalization of medical cannabis (81.1%) and expressed willingness to undergo treatment if medically indicated (84.3%). However, only 4.2% reported having received a recommendation for medical cannabis from a physician. Confidence in physicians' (29.9%) and patients' (16.1%) knowledge about medical cannabis was low. Oncological conditions (57.4%) and chronic pain (49.8%) were the most frequently recognized therapeutic indications. Support for home cultivation was associated with prior medical cannabis use, male gender, younger age, and urban residence. Older adults (≥50 years) were more likely to support legalization, whereas those aged 30-39 and individuals with moderate household income were less accepting. Conclusion: While public support for medical cannabis in Poland is high, its clinical implementation remains limited. Bridging this gap will require comprehensive educational initiatives and evidence-based guidelines to support healthcare professionals and inform patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.